Followers

August 20, 2024

Aurobindo Pharma to commercialise China plant in third quarter of FY25: CFO

​The company's Rs 2,400 crore Pen-G plant in Andhra Pradesh, which was approved under Production-Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the country, will have a production capacity of around 15,000 tonnes annually.

from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/IBl5ypo

No comments:

Post a Comment